In the language of laboratory synthesis, primary metabolic pathways are target-oriented, whereas secondary pathways are diversity-oriented. Is biosynthetic molecular promiscuity a bug or a feature?

Secondary metabolism consists of metabolic pathways and products of metabolism that are not absolutely required for the survival of the plant. Secondary metabolism is responsible for many ...

For example, in plants, specific metabolic pathways can produce glucose and chlorophyll. Metabolic pathways can be described as a series of chemical reactions that start with a substrate and ...

Metabolic pathways can be reversible or irreversible. Almost all pathways are reversible. If a specific enzyme or substrate isn’t available in a pathway then sometimes an end product can still ...

Recent studies highlight autophagy's crucial role in plant responses to nutrient scarcity, stress management, and pathogen interactions, and its influence on plant yield and metabolism. However, while ...

"Dyslipidemia" refers to an abnormality within the lipid profile, encompassing a variety of disorders relating to elevations in total cholesterol, LDL, or TG, or conversely, lower levels of HDL ...

Metabolic pathways of C3 and C4 plants. (Credit: Williams et al., 2013) What this tells us is that many plants – including food crops and species of trees – which use the C 3 carbon fixing ...

The study of endocrinology and metabolism encompasses topics including neuroendocrinology, reproductive endocrinology, pancreatic hormones and diabetes, regulation of bone formation and loss ...

Horticulture Research published research titled "Engineering the polyphenolic biosynthetic pathway stimulates metabolic and molecular changes during fruit ripening ... ripening stages to understand ...

Zoledronic acid treatment was associated with reduced fracture rates among pediatric patients with primary and secondary skeletal fragility.

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced ...